Compare FMC Corp (FMC) vs iShares MSCI China ETF (MCHI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs iShares MSCI China ETF — how do they compare? FMC Corp trades at $11.38 (market cap $1.36B), while iShares MSCI China ETF trades at $54.16. The key difference: FMC Corp pays a 2.95% dividend while iShares MSCI China ETF pays none, and iShares MSCI China ETF is trading nearer its 52-week high, FMC Corp nearer its low. Which is the better fit depends on your goals.
| FMC | MCHI | |
|---|---|---|
Market Cap | $1.36B | — |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $43.90 | $66.99 |
52-Week Low | $10.72 | $50.48 |
Enterprise Value | $5.50B | — |
Dividend Yield | 2.95% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.
The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.
MCHI trades at $54.29, up 1.99% with a bullish technical signal from moving averages, though oscillators are neutral. The stock shows strong momentum near recent highs, supported by China's AI-driven factory rebound and export growth. Recent news highlights China's $295 billion AI infrastructure plan and robust trade data, though geopolitical tensions with the U.S. pose headwinds.
Outlook remains mixed: AI sector tailwinds and undervaluation offer upside, but structural risks and analyst skepticism suggest caution. Key risks include U.S.-China tech rivalry and domestic economic pressures. Institutional sentiment is divided, with some seeing value while others warn of a value trap.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About iShares MSCI China ETF
MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →
